In 2023, the sales of Non-Steroid Anti-inflammatory and Antirheumatic medicines in Germany stood at 575.63 million USD. Over the forecast period from 2024 to 2027, a consistent decline in sales is projected.
Year-on-year variations from 2024 onwards exhibit a negative trend:
- 2024: -1.26%
- 2025: -1.25%
- 2026: -1.25%
- 2027: -1.23%
Analyzing the cumulative change from 2023 to 2027, there is a CAGR of approximately -1.25%. This consistent decline indicates a gradual reduction in market size.
Future trends to watch for include potential advancements in alternative treatments, changes in regulatory policies, and the impact of new entrants into the market. Further, economic factors or shifts in public health strategies could influence future sales dynamics in this segment.
